作者: S. A. Botha , A. P. Lötter , J. L. Du Preez
DOI: 10.3109/03639048709040177
关键词: Pharmacology 、 Capsule Dosage Form 、 Salicylamide 、 Phenylephrine Hydrochloride 、 Ascorbic acid 、 Drug 、 Chemistry 、 Pyrilamine Maleate 、 Phenylephrine
摘要: AbstractDSC screening for drug-drug interactions of a polypharmaceutical capsule dosage form containing salicylaminde, ascorbic acid, pyrilamine maleate and phenylephrine hydrochloride was performed. The results show the following:1. Ascorbic acid is incompatible with salicylamide, pheynylephrine hydrochloride.2. Salicylamide hydrochloride.3. Pyrilamine salicylamide hydrochloride.4. Phenylephrine acid.